SEC Form 4 · accession 0001209191-19-005543
Cue Biopharma, Inc. · CUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cameron Gray
Director
Period of report
Dec 29, 2017
Accepted (ET)
Jan 28, 2019 · 4:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645460
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants | $9.375 | Dec 29, 2017 | J | 192,495 | A | Jun 12, 2018 | Dec 14, 2022 | Common Stock | 192,495 | 192,495 | D |
Explanation of responses
- F1Upon closing of the initial public offering of the Issuer, the Warrants were issued to MDB Capital Group LLC ("MDB") as partial consideration for services as underwriter. MDB assigned a portion of the Warrants to the reporting person effective December 29, 2017.